# Rackspace Technology, Inc.: financial statements, quarterly

RXT · Nasdaq · CIK 1810019 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rxt.md) · [Financials](/companies/rxt/financials.md) · [Filings](/companies/rxt/filings.md) · [Insiders](/companies/rxt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rxt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [732](/filings/0001810019-24-000159.md) | [720 d](/filings/0001810019-26-000015.md) | [691](/filings/0001810019-25-000069.md) | [685](/filings/0001810019-25-000110.md) | [676](/filings/0001810019-25-000153.md) | [686 d](/filings/0001810019-26-000015.md) | [665](/filings/0001810019-26-000044.md) | [666](/filings/0001810019-26-000093.md) | [671](/filings/0001810019-25-000153.md) | [683 d](/filings/0001810019-26-000015.md) | [678](/filings/0001810019-26-000044.md) | [670](/filings/0001810019-26-000093.md) |
| Cost of revenue | $m | [580](/filings/0001810019-24-000159.md) | [566 d](/filings/0001810019-26-000015.md) | [558](/filings/0001810019-25-000069.md) | [554](/filings/0001810019-25-000110.md) | [538](/filings/0001810019-25-000153.md) | [554 d](/filings/0001810019-26-000015.md) | [539](/filings/0001810019-26-000044.md) | [537](/filings/0001810019-26-000093.md) | [541](/filings/0001810019-25-000153.md) | [562 d](/filings/0001810019-26-000015.md) | [559](/filings/0001810019-26-000044.md) | [555](/filings/0001810019-26-000093.md) |
| Gross profit | $m | [152](/filings/0001810019-24-000159.md) | [154 d](/filings/0001810019-26-000015.md) | [133](/filings/0001810019-25-000069.md) | [131](/filings/0001810019-25-000110.md) | [138](/filings/0001810019-25-000153.md) | [132 d](/filings/0001810019-26-000015.md) | [127](/filings/0001810019-26-000044.md) | [129](/filings/0001810019-26-000093.md) | [130](/filings/0001810019-25-000153.md) | [120 d](/filings/0001810019-26-000015.md) | [119](/filings/0001810019-26-000044.md) | [115](/filings/0001810019-26-000093.md) |
| Selling, general and administrative | $m | [177](/filings/0001810019-24-000159.md) | [166 d](/filings/0001810019-26-000015.md) | [192](/filings/0001810019-25-000069.md) | [185](/filings/0001810019-25-000110.md) | [170](/filings/0001810019-25-000153.md) | [161 d](/filings/0001810019-26-000015.md) | [165](/filings/0001810019-26-000044.md) | [154](/filings/0001810019-26-000093.md) | [164](/filings/0001810019-25-000153.md) | [124 d](/filings/0001810019-26-000015.md) | [137](/filings/0001810019-26-000044.md) | [148](/filings/0001810019-26-000093.md) |
| Operating income | $m | [(239)](/filings/0001810019-24-000159.md) | [(15.2) d](/filings/0001810019-26-000015.md) | [(653)](/filings/0001810019-25-000069.md) | [(53.8)](/filings/0001810019-25-000110.md) | [(174)](/filings/0001810019-25-000153.md) | [(28.8) d](/filings/0001810019-26-000015.md) | [(38.4)](/filings/0001810019-26-000044.md) | [(25.1)](/filings/0001810019-26-000093.md) | [(33.9)](/filings/0001810019-25-000153.md) | [(3.3) d](/filings/0001810019-26-000015.md) | [(17.8)](/filings/0001810019-26-000044.md) | [(33.2)](/filings/0001810019-26-000093.md) |
| Interest expense | $m | [56.5](/filings/0001810019-23-000164.md) | [50.9 d](/filings/0001810019-24-000042.md) | [43.7](/filings/0001810019-24-000094.md) | [18.4](/filings/0001810019-25-000110.md) | [18.0](/filings/0001810019-25-000153.md) | [17.9 d](/filings/0001810019-26-000015.md) | [19.4](/filings/0001810019-26-000044.md) | [21.3](/filings/0001810019-26-000093.md) | [21.2](/filings/0001810019-25-000153.md) | [20.8 d](/filings/0001810019-26-000015.md) | [26.2](/filings/0001810019-26-000044.md) | [34.2](/filings/0001810019-26-000093.md) |
| Income tax | $m | [(16.5)](/filings/0001810019-24-000159.md) | [9.5 d](/filings/0001810019-26-000015.md) | [(4.7)](/filings/0001810019-25-000069.md) | [(29.9)](/filings/0001810019-25-000110.md) | [12.0](/filings/0001810019-25-000153.md) | [(0.7) d](/filings/0001810019-26-000015.md) | [8.2](/filings/0001810019-26-000044.md) | [4.6](/filings/0001810019-26-000093.md) | [8.1](/filings/0001810019-25-000153.md) | [3.1 d](/filings/0001810019-26-000015.md) | [(0.1)](/filings/0001810019-26-000044.md) | [1.8](/filings/0001810019-26-000093.md) |
| Net income | $m | [(227)](/filings/0001810019-24-000159.md) | [28.0 d](/filings/0001810019-26-000015.md) | [(641)](/filings/0001810019-25-000069.md) | [25.0](/filings/0001810019-25-000110.md) | [(187)](/filings/0001810019-25-000153.md) | [(56.0) d](/filings/0001810019-26-000015.md) | [(71.5)](/filings/0001810019-26-000044.md) | [(54.5)](/filings/0001810019-26-000093.md) | [(67.1)](/filings/0001810019-25-000153.md) | [(32.7) d](/filings/0001810019-26-000015.md) | [8.3](/filings/0001810019-26-000044.md) | [(67.5)](/filings/0001810019-26-000093.md) |
| Diluted EPS | $ per share | [(1.05)](/filings/0001810019-24-000159.md) | not reported | [(2.91)](/filings/0001810019-25-000069.md) | [0.11](/filings/0001810019-25-000110.md) | [(0.82)](/filings/0001810019-25-000153.md) | not reported | [(0.31)](/filings/0001810019-26-000044.md) | [(0.23)](/filings/0001810019-26-000093.md) | [(0.28)](/filings/0001810019-25-000153.md) | not reported | [0.03](/filings/0001810019-26-000044.md) | [(0.27)](/filings/0001810019-26-000093.md) |
| Basic EPS | $ per share | [(1.05)](/filings/0001810019-24-000159.md) | not reported | [(2.91)](/filings/0001810019-25-000069.md) | [0.11](/filings/0001810019-25-000110.md) | [(0.82)](/filings/0001810019-25-000153.md) | not reported | [(0.31)](/filings/0001810019-26-000044.md) | [(0.23)](/filings/0001810019-26-000093.md) | [(0.28)](/filings/0001810019-25-000153.md) | not reported | [0.03](/filings/0001810019-26-000044.md) | [(0.27)](/filings/0001810019-26-000093.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [278](/filings/0001810019-24-000159.md) | [197](/filings/0001810019-26-000015.md) | [283](/filings/0001810019-25-000069.md) | [190](/filings/0001810019-25-000110.md) | [157](/filings/0001810019-25-000153.md) | [144](/filings/0001810019-26-000015.md) | [128](/filings/0001810019-26-000044.md) | [104](/filings/0001810019-26-000093.md) | [99.5](/filings/0001810019-25-000153.md) | [106](/filings/0001810019-26-000093.md) | [93.6](/filings/0001810019-26-000044.md) | [111](/filings/0001810019-26-000093.md) |
| Current assets | $m | [845](/filings/0001810019-23-000164.md) | [738](/filings/0001810019-25-000043.md) | [788](/filings/0001810019-24-000094.md) | [696](/filings/0001810019-24-000132.md) | [649](/filings/0001810019-24-000159.md) | [619](/filings/0001810019-26-000015.md) | [582](/filings/0001810019-25-000069.md) | [548](/filings/0001810019-25-000110.md) | [541](/filings/0001810019-25-000153.md) | [518](/filings/0001810019-26-000093.md) | [535](/filings/0001810019-26-000044.md) | [556](/filings/0001810019-26-000093.md) |
| Total assets | $m | [4,280](/filings/0001810019-23-000164.md) | [4,096](/filings/0001810019-25-000043.md) | [3,516](/filings/0001810019-24-000094.md) | [3,394](/filings/0001810019-24-000132.md) | [3,146](/filings/0001810019-24-000159.md) | [3,054](/filings/0001810019-26-000015.md) | [2,966](/filings/0001810019-25-000069.md) | [2,895](/filings/0001810019-25-000110.md) | [2,845](/filings/0001810019-25-000153.md) | [2,800](/filings/0001810019-26-000093.md) | [2,765](/filings/0001810019-26-000044.md) | [2,745](/filings/0001810019-26-000093.md) |
| Current liabilities | $m | [825](/filings/0001810019-23-000164.md) | [800](/filings/0001810019-25-000043.md) | [754](/filings/0001810019-24-000094.md) | [771](/filings/0001810019-24-000132.md) | [769](/filings/0001810019-24-000159.md) | [767](/filings/0001810019-26-000015.md) | [735](/filings/0001810019-25-000069.md) | [715](/filings/0001810019-25-000110.md) | [766](/filings/0001810019-25-000153.md) | [767](/filings/0001810019-26-000093.md) | [786](/filings/0001810019-26-000044.md) | [736](/filings/0001810019-26-000093.md) |
| Total liabilities | $m | [4,463](/filings/0001810019-23-000164.md) | [4,251](/filings/0001810019-25-000043.md) | [4,303](/filings/0001810019-24-000094.md) | [4,150](/filings/0001810019-24-000132.md) | [4,096](/filings/0001810019-24-000159.md) | [4,058](/filings/0001810019-26-000015.md) | [4,039](/filings/0001810019-25-000069.md) | [4,014](/filings/0001810019-25-000110.md) | [4,032](/filings/0001810019-25-000153.md) | [4,019](/filings/0001810019-26-000093.md) | [3,982](/filings/0001810019-26-000044.md) | [4,026](/filings/0001810019-26-000093.md) |
| Long-term debt | $m | [3,012](/filings/0001810019-23-000164.md) | [2,840](/filings/0001810019-25-000043.md) | [2,974](/filings/0001810019-24-000094.md) | [2,816](/filings/0001810019-24-000132.md) | [2,782](/filings/0001810019-24-000159.md) | [2,756](/filings/0001810019-26-000015.md) | [2,762](/filings/0001810019-25-000069.md) | [2,767](/filings/0001810019-25-000110.md) | [2,742](/filings/0001810019-25-000153.md) | [2,719](/filings/0001810019-26-000093.md) | [2,682](/filings/0001810019-26-000044.md) | [2,762](/filings/0001810019-26-000093.md) |
| Current portion of debt | $m | [47.4](/filings/0001810019-23-000164.md) | [23.0](/filings/0001810019-25-000043.md) | [20.3](/filings/0001810019-24-000094.md) | [54.0](/filings/0001810019-24-000132.md) | [27.1](/filings/0001810019-24-000159.md) | [29.2](/filings/0001810019-26-000015.md) | [25.8](/filings/0001810019-25-000069.md) | [33.4](/filings/0001810019-25-000110.md) | [30.4](/filings/0001810019-25-000153.md) | [27.3](/filings/0001810019-26-000093.md) | [26.6](/filings/0001810019-26-000044.md) | [24.8](/filings/0001810019-26-000093.md) |
| Shareholders' equity | $m | [(183)](/filings/0001810019-24-000159.md) | [(155)](/filings/0001810019-26-000015.md) | [(787)](/filings/0001810019-25-000110.md) | [(756)](/filings/0001810019-25-000153.md) | [(950)](/filings/0001810019-25-000153.md) | [(1,004)](/filings/0001810019-26-000093.md) | [(1,073)](/filings/0001810019-26-000093.md) | [(1,119)](/filings/0001810019-26-000093.md) | [(1,187)](/filings/0001810019-25-000153.md) | [(1,220)](/filings/0001810019-26-000093.md) | [(1,217)](/filings/0001810019-26-000093.md) | [(1,281)](/filings/0001810019-26-000093.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [267 d](/filings/0001810019-24-000159.md) | [72.2 d](/filings/0001810019-26-000015.md) | [(90.3)](/filings/0001810019-25-000069.md) | [24.1 d](/filings/0001810019-25-000110.md) | [51.8 d](/filings/0001810019-25-000153.md) | [54.3 d](/filings/0001810019-26-000015.md) | [12.6](/filings/0001810019-26-000044.md) | [8.4 d](/filings/0001810019-26-000093.md) | [70.7 d](/filings/0001810019-25-000153.md) | [59.7 d](/filings/0001810019-26-000015.md) | [5.1](/filings/0001810019-26-000044.md) | [(31.5) d](/filings/0001810019-26-000093.md) |
| Capital expenditure | $m | [27.5 d](/filings/0001810019-24-000159.md) | [33.9 d](/filings/0001810019-26-000015.md) | [28.1](/filings/0001810019-25-000069.md) | [38.6 d](/filings/0001810019-25-000110.md) | [24.5 d](/filings/0001810019-25-000153.md) | [19.9 d](/filings/0001810019-26-000015.md) | [8.3](/filings/0001810019-26-000044.md) | [20.8 d](/filings/0001810019-26-000093.md) | [28.0 d](/filings/0001810019-25-000153.md) | [3.7 d](/filings/0001810019-26-000015.md) | [14.5](/filings/0001810019-26-000044.md) | [16.8 d](/filings/0001810019-26-000093.md) |
| Share repurchases | $m | [0.0 d](/filings/0001810019-23-000164.md) | [0.0 d](/filings/0001810019-25-000043.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [211](/filings/0001810019-23-000164.md) | [213](/filings/0001810019-24-000094.md) | [215](/filings/0001810019-24-000132.md) | [216](/filings/0001810019-24-000159.md) | [220](/filings/0001810019-25-000069.md) | [230](/filings/0001810019-25-000110.md) | [226](/filings/0001810019-25-000153.md) | [232](/filings/0001810019-26-000044.md) | [238](/filings/0001810019-26-000093.md) | [240](/filings/0001810019-25-000153.md) | [250](/filings/0001810019-26-000044.md) | [250](/filings/0001810019-26-000093.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 254,872,850 at 2026-08-04, from the cover of the [10-Q filed 2026-08-10](/filings/0001810019-26-000093.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.